Clinicaltrialvanguard

Published September 15, 2026 · Updated September 16, 2026

Definium's DT120 ODT Meets Primary Endpoint in Phase 3 GAD Study

Read the full story at Clinicaltrialvanguard

A psychedelic -derived compound clearing a Phase 3 bar in anxiety would be a different kind of news entirely, and Definium now has that data in hand.